Detalles de la búsqueda
1.
Clinical Pharmacology of RNA Interference-Based Therapeutics: A Summary Based on Food and Drug Administration-Approved Small Interfering RNAs.
Drug Metab Dispos
; 51(2): 193-198, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36332914
2.
FDA Public Workshop Summary-Coccidioidomycosis (Valley Fever): Considerations for Development of Antifungal Drugs.
Clin Infect Dis
; 74(11): 2061-2066, 2022 06 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34651656
3.
Application of Population Pharmacokinetic Modeling, Exposure-Response Analysis, and Classification and Regression Tree Analysis to Support Dosage Regimen and Therapeutic Drug Monitoring of Plazomicin in Complicated Urinary Tract Infection Patients with Renal Impairment.
Antimicrob Agents Chemother
; 66(4): e0207421, 2022 04 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-35258314
4.
A Regulatory Review Approach for Evaluation of Micafungin for Treatment of Neonatal Candidiasis.
Clin Infect Dis
; 73(12): 2335-2340, 2021 12 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-33458754
5.
Effect of Body Weight and Age on the Pharmacokinetics of Dihydroartemisinin: Food and Drug Administration Basis for Dose Determination of Artesunate for Injection in Pediatric Patients With Severe Malaria.
Clin Infect Dis
; 73(5): 903-906, 2021 09 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33605994
6.
Variations in pharmacokinetic-pharmacodynamic target values across MICs and their potential impact on determination of susceptibility test interpretive criteria.
J Antimicrob Chemother
; 76(11): 2884-2889, 2021 10 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34347077
7.
Blueprint for pandemic response: Focus on translational medicine, clinical pharmacology and pharmacometrics.
Br J Clin Pharmacol
; 87(9): 3398-3407, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33855747
8.
Connecting Hydroxychloroquine In Vitro Antiviral Activity to In Vivo Concentration for Prediction of Antiviral Effect: A Critical Step in Treating Patients With Coronavirus Disease 2019.
Clin Infect Dis
; 71(12): 3232-3236, 2020 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32435791
9.
Reply to White et al.
Clin Infect Dis
; 75(2): 359, 2022 Aug 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-35023546
10.
A Modified Delphi Study to Establish Essential Clinical Pharmacology Competencies.
Ther Innov Regul Sci
; 58(3): 473-482, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38319585
11.
Pharmacokinetics of Antiretroviral Agents in Pregnant Individuals Living With HIV: Current Status and Considerations for Study Design and Interpretation.
J Clin Pharmacol
; 63 Suppl 1: S176-S187, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37317501
12.
Using Endogenous Biomarkers to Derisk Assessment of Transporter-Mediated Drug-Drug Interactions: A Scientific Perspective.
J Clin Pharmacol
; 62(12): 1501-1506, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35778968
13.
Current Perspective on Residual Knowledge Gaps in the Assessment of Transporter-Mediated Drug Interactions.
Clin Pharmacol Ther
; 112(3): 450-452, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35722741
14.
Cefiderocol Dosing for Patients Receiving Continuous Renal Replacement Therapy.
Clin Pharmacol Ther
; 112(5): 1004-1007, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35792715
15.
Whole Body PBPK Modeling of Remdesivir and Its Metabolites to Aid in Estimating Active Metabolite Exposure in the Lung and Liver in Patients With Organ Dysfunction.
Clin Pharmacol Ther
; 111(3): 624-634, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34656075
16.
Evaluating Patients With Impaired Renal Function During Drug Development: Highlights From the 2019 US FDA Pharmaceutical Science and Clinical Pharmacology Advisory Committee Meeting.
Clin Pharmacol Ther
; 110(2): 285-288, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33411946
17.
Anti-SARS-CoV-2 Repurposing Drug Database: Clinical Pharmacology Considerations.
CPT Pharmacometrics Syst Pharmacol
; 10(9): 973-982, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34218521
18.
Drug interactions evaluation: an integrated part of risk assessment of therapeutics.
Toxicol Appl Pharmacol
; 243(2): 134-45, 2010 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20045016
19.
Does Hepatic Impairment Affect the Exposure of Monoclonal Antibodies?
Clin Pharmacol Ther
; 107(5): 1256-1262, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31899819
20.
Evaluation of Hemodialysis Effect on Pharmacokinetics of Meropenem/Vaborbactam in End-Stage Renal Disease Patients Using Modeling and Simulation.
J Clin Pharmacol
; 60(8): 1011-1021, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32149406